171049-67-5

Basic information

• Product Name: tert-butyl-3-(bromomethyl)-4-nitrobenzoate
• Synonyms: tert-butyl-3-(bromomethyl)-4-nitrobenzoate
• CAS NO: 171049-67-5
• Molecular Weight: 316.151
• Mol File: 171049-67-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl-3-(bromomethyl)-4-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl-3-(bromomethyl)-4-nitrobenzoate(171049-67-5)
• EPA Substance Registry System: tert-butyl-3-(bromomethyl)-4-nitrobenzoate(171049-67-5)

Safety Data

• Hazardous Substances Data: 171049-67-5(Hazardous Substances Data)

Upstream product

• 3113-71-1 3-methyl-4-nitrobenzoic acid 
• 147290-67-3 tert-butyl 3-methyl-4-nitrobenzoate 

Downstream Products

• 171049-68-6 tert-butyl 3-(3-methylaminomethyl)-4-nitrobenzoate 
• 175530-17-3 tert-Butyl 4-amino-3-[[bis-(t-butoxycarbonyl)]amino]methylbenzoate 
• 175530-16-2 tert-Butyl 3-[[bis-(t-butoxycarbonyl)]amino]methyl-4-nitrobenzoate 
• 334999-86-9 tert-butyl 3-[(phenylamino)methyl]-4-nitro benzoate 
• 171049-45-9 [7-(4-{Amino-[(Z)-benzyloxycarbonylimino]-methyl}-phenylcarbamoyl)-3-oxo-4-phenethyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl]-acetic acid methyl ester 
• 147290-71-9 2-{4-tert-Butoxycarbonyl-2-[(tert-butoxycarbonyl-phenethyl-amino)-methyl]-phenylamino}-succinic acid dimethyl ester 
• 292135-38-7 [7-(4-Carbamimidoyl-phenylcarbamoyl)-3-oxo-4-phenethyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl]-acetic acid methyl ester 
• 171049-34-6 methyl 7-carboxy-3-oxo-1,4-benzodiazepine-2-acetate 
• 147290-69-5 t-butyl 4-nitro-3-[N-(t-butyloxycarbonyl)-N-(2-phenyl-ethyl)aminomethyl]benzoate 
• 147290-70-8 tert-butyl 4-amino-3-[[N-(tert-butoxycarbonyl)-N-phenethylamino]methyl]benzoate 
• 446263-90-7 tert-butyl-4-nitro-3-[(N-methylacetylamino)methyl]benzoate 
• 334999-61-0 tert-butyl 3-[(N-acetyl-N-methylamino)methyl]-4-aminobenzoate 
• 147290-68-4 t-butyl 4-nitro-3-[N-(2-phenylethyl)aminomethyl]benzoate 

Relevant articles and documents

Fab I inhibitors

Compounds of the formula (I) are disclosed which are FabI inhibitors and are useful in the treatment of bacterial infections.

Bicyclic fibrinogen antagonists

PCT No. PCT/US95/00248 Sec. 371 Date Jul. 3, 1996 Sec. 102(e) Date Jul. 3, 1996 PCT Filed Jan. 9, 1995 PCT Pub. No. WO96/18619 PCT Pub. Date Jul. 13, 1995Certain compounds within formula (I) are inhibitors of platelet aggregation: wherein A1 is NH or CH2;